General Article

COVID Disaster Has Stalled Struggle Towards HIV/AIDS

News Picture: COVID Crisis Has Stalled Fight Against HIV/AIDS

THURSDAY, July 28, 2022 (HealthDay Information)

Efforts to finish the worldwide HIV epidemic have slowed as cash and a focus pass towards combating COVID-19, new record displays.

“That is an alarm to the arena to mention that COVID-19 has blown the AIDS reaction considerably off monitor,” Matthew Kavanaugh, deputy government director of UNAIDS, stated of the findings.

A number of the considerations are that HIV trying out has slowed or stopped in puts coping with COVID surges. HIV infections have climbed in portions of Asia and the Pacific, the place they’d been falling.

A world decline in new infections is leveling off as a substitute of shedding because it were for years, endangering the United International locations’ purpose of fewer than 370,000 new HIV infections by way of 2025. Final 12 months there have been nonetheless 1.5 million. About 650,000 other people died final 12 months from AIDS-related diseases, the record discovered.

“Persons are exhausted with epidemics and pandemics,” Dr. Anthony Fauci, the U.S. executive’s main AIDS knowledgeable and director of the U.S. Nationwide Institute of Hypersensitive reaction and Infectious Sicknesses, instructed the Related Press. “We need to struggle two times as laborious to get HIV again at the radar display the place it belongs.”

Disparities keep growing for girls and women. In sub-Saharan Africa, girls and teenage women are thrice as more likely to get HIV as boys and males. A teenager lady or girl used to be newly inflamed each two mins final 12 months, the AP reported.

In the meantime global support has dropped, leaving low- and middle-income international locations with $8 billion not up to they wish to fund efforts, the record discovered.

Against this to those troubling alarms, the Global AIDS convention in Montreal this week will spotlight promising development in efforts to regard the ones with the illness.

For instance, scientists are taking a look on the case of a girl in Spain, the place her personal immune device turns out to have stored her HIV at an undetectable degree for 15 years. She used to be a part of a analysis learn about in 2006 that incorporated immune-boosting therapies. College of Barcelona researchers don’t seem to be positive why she’s doing so smartly, the AP reported.

And in america, a 66-year-old HIV-positive guy had a bone marrow-like transplant to struggle leukemia in 2019. He is now in remission and has been off his AIDS medicine for 17 months with out a indicators of HIV, in step with Dr. Jana Dickter of Town of Hope, a California most cancers analysis middle.

The person, who had HIV for 30 years, gained transplanted stem cells from a donor who came about to hold a unprecedented gene mutation that made the cells immune to HIV.

The affected person persisted to take his HIV medicine till he gained a COVID-19 vaccine. He’s each the oldest and longest-living particular person with HIV to go through this probably healing transplant, in step with the AP.

Additional information

The AIDS Healthcare Basis has extra on HIV/AIDS.

SOURCE: Related Press

Through Cara Murez HealthDay Reporter

MedicalNews

Copyright © 2021 HealthDay. All rights reserved.





QUESTION


What’s HIV?
See Resolution

General Article

Do not Use Luvox, Colchicine to Battle COVID, WHO Professionals Say

News Picture: Don't Use Luvox, Colchicine to Fight COVID, WHO Experts Say

FRIDAY, July 15, 2022 (HealthDay Information)

Other people should not take the medicine colchicine and fluvoxamine to regard gentle to reasonable COVID-19, the Global Well being Group (WHO) is caution.

The antidepressant drug fluvoxamine (Luvox) and the gout drug colchicine are repeatedly used and reasonably priced medication that experience gained really extensive pastime as attainable COVID-19 remedies.

Then again, there’s inadequate proof that both drug improves vital results for sufferers, in step with a WHO document produced by way of a panel of professionals and just lately printed on-line in The BMJ.

Fluvoxamine will have to best be utilized in medical trials, the WHO document instructed, in keeping with information from 3 randomized managed trials involving greater than 2,000 sufferers.

The group strongly instructed in opposition to the usage of colchicine in any respect, in keeping with information from seven medical trials involving just about 16,500 sufferers.

After reviewing the proof, the WHO panel concluded that the majority well-informed sufferers will have to select to not take both drug for COVID-19.

Prior to now, the WHO has strongly advisable using nirmatrelvir and ritonavir in treating COVID-19. It has additionally issued conditional suggestions for sotrovimab, remdesivir and molnupiravir for high-risk sufferers with non-severe COVID.

For sufferers with extreme COVID-19, the WHO strongly recommends corticosteroids, with the addition of IL-6 receptor blockers or baricitinib, the panel mentioned in a magazine information unencumber.

Nevertheless it advises in opposition to using convalescent plasma, ivermectin and hydroxychloroquine in COVID sufferers, regardless of how extreme their illness.

Additional info

The U.S. Facilities for Illness Keep watch over and Prevention has extra about COVID treatments.

SOURCE: The BMJ, information unencumber, July 13, 2022

By way of Dennis Thompson HealthDay Reporter

MedicalNews

Copyright © 2021 HealthDay. All rights reserved.

General Article

Harnessing a Virus to Combat a Killer Mind Tumor in Children

News Picture: Harnessing a Virus to Fight a Killer Brain Tumor in KidsThrough Amy Norton HealthDay Reporter

THURSDAY, June 30, 2022 (HealthDay Information)

A treatment that makes use of a virulent disease to kill tumor cells will also be safely given to kids with an extraordinary, incurable type of mind most cancers, an early learn about has discovered.

The learn about — revealed June 30 within the New England Magazine of Drugs — concerned simply 12 kids with the illness, referred to as diffuse intrinsic pontine glioma (DIPG).

However mavens stated it demonstrates the feasibility of without delay handing over the viral treatment to the most cancers, which paperwork within the mind stem.

Whether or not the method can in the long run prolong kids’s lives, then again, is still noticed.

DIPG is uncommon, affecting between 200 and 400 U.S. kids each and every 12 months. There’s no remedy, largely on account of the character of the most cancers: It arises in part of the mind stem referred to as the pons, which controls physically purposes as crucial as respiring and middle price. Complicating issues, the tumors are thread-like and interweave with standard mind tissue — making it inconceivable to surgically take away the most cancers.

So at the moment, radiation is the principle treatment for DIPG.

“Within the majority of sufferers, however no longer all, the most cancers will to start with reply to radiation,” stated Dr. Susan Chi, deputy director of pediatric neuro-oncology at Dana-Farber Most cancers Institute/Boston Youngsters’s Sanatorium.

Sadly, she defined, that most effective buys time, because the most cancers nearly invariably progresses once more. Many kids identified with DIPG die inside of a 12 months, and few — not up to 10% — live to tell the tale for 2 years, research display.

“That is almost certainly the worst tumor prognosis we give to households,” stated Chi, who used to be no longer concerned within the new learn about.

For the trial, researchers in Spain, the Netherlands and United States became to oncolytic virus treatment, an method that has been below learn about for positive cancers, together with different mind tumors. The idea is in keeping with the truth that some viruses can infect and kill tumor cells.

Virus treatment comes to viruses which have been changed within the lab to contaminate and reproduce successfully within most cancers cells whilst leaving wholesome cells by myself. One such treatment — a genetically changed herpesvirus — is licensed within the U.S. for treating melanoma.

Right here, the researchers used a changed chilly virus, referred to as DNX-2401, which has been proven to kill DIPG cells in lab animals. The use of a specifically designed cannula (a skinny tube), the researchers slowly infused the viral treatment into the tumors of 12 kids and teenagers newly identified with DIPG. The sufferers then gained usual radiation.

The primary purpose used to be to evaluate the security of the process, in step with the researchers, who have been led by means of Dr. Jaime Gallego Perez-Larraya of the Well being Analysis Institute of Navarra in Spain.

And general, the most typical unwanted side effects have been headache, nausea, vomiting and fatigue. Two kids did broaden vital limb weak spot (transient in a single case), which is without doubt one of the issues with “going into the pons,” Chi stated.

Sadly, many of the kids sooner or later succumbed to their illness, however the median survival — at nearly 18 months — used to be upper than in most cases noticed in DIPG. Median way part lived longer, part for a shorter time.




QUESTION


Which of those is NOT a kind of head and neck most cancers?
See Solution

Chi cautioned, then again, that “it is too quickly to attract conclusions.”

Some kids with DIPG do reside that lengthy, she famous, and it isn’t transparent that the viral treatment itself — versus the radiation treatment — prolonged some youngsters’ lives.

Alternatively, Chi identified, two kids have been nonetheless alive previous the 30-month mark. That incorporated one kid who used to be progression-free after 38 months.

Dr. Evanthia Galanis, an oncologist on the Mayo Hospital in Rochester, Minn., who research oncolytic virus treatment, referred to as the early findings “encouraging.”

“The method used to be well-tolerated, and the virus went the place it used to be intended to,” stated Galanis, who wrote an article revealed with the learn about.

Like Chi, she stated the survival findings will have to be interpreted with warning, for the reason that trial used to be basically designed to evaluate protection.

In line with Galanis, researchers to start with believed oncolytic viruses may paintings by means of without delay killing tumor cells — replicating inside of them till the cells burst. However through the years, research have proven that the method might also

General Article

Gout Medication Would possibly Additionally Lend a hand Combat Middle Failure

News Picture: Gout Medicine May Also Help Fight Heart Failure

MONDAY, Would possibly 23, 2022 (HealthDay Information)

The anti inflammatory advantages of a commonplace gout medication would possibly assist save the lives of center failure sufferers, researchers say.

The drugs, colchicine, may just additionally cut back the chance of center assault and stroke in sufferers whose arteries are clogged with ldl cholesterol, consistent with the find out about authors.

“The sign for get advantages with colchicine in those sufferers used to be very spectacular, and I be expecting that those findings could have rather an important affect on medical care in center failure and long term analysis for sufferers with this situation,” Dr. Kenneth Bilchick mentioned in a College of Virginia (UVA) information unencumber. He is a professor of cardiovascular medication there.

For the find out about, Bilchick and his staff analyzed the information of greater than 1,000 sufferers admitted to the college’s Clinical Middle between March 2011 and February 2020 for worsening center failure, which happens when the center cannot pump sufficient blood during the frame.

Survival charges have been just about 98% for individuals who gained colchicine for a gout flare, when compared with not up to 94% for individuals who were not given colchicine.

Many sufferers with center failure even have gout, a kind of arthritis brought about by means of a buildup of uric acid crystals within the joints.

Not unusual remedies for gout come with colchicine, steroids and nonsteroidal anti inflammatory medicine (NSAIDs), equivalent to aspirin and ibuprofen. Then again, steroids and NSAIDs don’t seem to be normally given to center failure sufferers as a result of they may aggravate center failure signs.

Colchicine could gain advantage center failure sufferers by means of decreasing irritation within the center and blood vessels, the researchers recommended.

Whilst those preliminary findings wish to be showed in huge research, the analysis staff mentioned they’re promising.

“Those effects spotlight the significance of novel inflammatory mechanisms in center failure,” Bilchick mentioned.

Middle failure is greater than only a failure of the pumping serve as of the center, mentioned Dr. Sula Mazimba, a UVA Faculty of Medication researcher and heart specialist. “There are different processes which are concerned, particularly all over an acute hospitalization section, equivalent to increased irritation and neuro-hormonal procedure. Most of the healing brokers for center failure goal neuro-hormonal pathways, however few if any goal inflammatory pathways,” Mazimba mentioned.

“Colchicine is a medicine that has anti inflammatory houses that might doubtlessly attenuate the heightened irritation that we see in sufferers who’re hospitalized with center failure,” Mazimba added.

About 6 million American citizens have center failure and it reasons greater than 86,000 deaths a yr, consistent with the American Middle Affiliation.

The find out about findings have been revealed on-line lately within the magazine Scientific Cardiology.

Additional info

Be told extra about center failure on the American Middle Affiliation.

SOURCE: College of Virginia, information unencumber, Would possibly 19, 2022

By way of Robert Preidt HealthDay Reporter

MedicalNews

Copyright © 2021 HealthDay. All rights reserved.





QUESTION


Within the U.S., 1 in each and every 4 deaths is brought about by means of center illness.
See Resolution

General Article

Estrogen Would possibly Assist Struggle Critical COVID-19

News Picture: Estrogen May Help Fight Severe COVID-19Via Alan Mozes HealthDay Reporter

Hormone alternative remedy might be offering girls important coverage in opposition to loss of life from COVID-19, new analysis suggests.

British researchers who tracked greater than 5,400 girls with COVID all through the primary part of 2020 document that those that won the supplemental estrogen had been 78% much less more likely to die inside of six months in their COVID prognosis.

Just about 5% of girls within the learn about have been taking hormone alternative remedy (HRT) earlier than their COVID prognosis. HRT is used to alleviate signs reminiscent of scorching flashes and insomnia led to by means of decrease ranges of estrogen and progesterone all through menopause.

“Additional analysis can be required earlier than lets counsel estrogen-containing medicines as remedy for COVID,” mentioned learn about creator Christopher Wilcox. He is an educational medical fellow in number one care and inhabitants well being on the College of Southampton.

Then again, he and his colleagues indicate that males with COVID are much more likely than girls to be hospitalized and admitted to an extensive care unit. Fresh knowledge from 38 nations additionally signifies that males are 1.7 instances much more likely to die from COVID than girls.

“Moderately a lot of research have proven that upper estrogen ranges appear to be related to decrease severity of infectious sicknesses, together with COVID-19,” Wilcox mentioned.

“Extra lately,” he added, “there were research suggesting that there might a protecting impact from estrogen-containing medicines, together with HRT and the blended oral contraceptive tablet.”

Nonetheless, he added, the proof for that has now not been constant.

To be told extra, Wilcox and his colleagues checked out number one care scientific data drawn from a big U.Ok. database. Of greater than 1.8 million girls in that database, 5,451 have been recognized with COVID by means of the tip of June 2020.

None had been proactively given HRT as a remedy following their COVID prognosis. And maximum had now not been on hormone remedy previously.

However 235 sufferers have been on an HRT routine all through the previous six months.

For all girls, the danger of loss of life inside of six months of a COVID prognosis used to be upper amongst those that had been older, overweight and/or suffering with different sicknesses. Girls on immunosuppressant medication additionally confronted a better possibility for dying.

However the workforce decided that the ones on HRT confronted a considerably decrease possibility.

Wilcox introduced imaginable explanations. “It’s concept that upper estrogen ranges is also related to greater immune responses,” he mentioned. “Fresh analysis means that this would partially give an explanation for why girls have a better and quicker COVID antibody reaction … when put next with males.”

However he stopped in need of suggesting that ladies start HRT after a COVID prognosis in a bid to achieve added coverage.

“I indubitably assume girls may also be inspired from those effects that there is not any indication to prevent HRT on account of the pandemic,” Wilcox mentioned. “Additional analysis can be required earlier than lets counsel estrogen-containing medicines as remedy for COVID.”

Dr. Thomas Intestine, an affiliate chair of medication with Northwell Well being at Staten Island College Medical institution (SIUH) in New York Town, seconded that concept.

“This isn’t one thing I have spotted myself, however it is fascinating,” mentioned Intestine, who reviewed the learn about findings. “And we do know that ladies who’ve been on HRT — particularly more youthful girls — might achieve some middle protecting advantages. So it can be that HRT is protective them from cardiovascular results that from time to time have an effect on COVID sufferers.”

However he mentioned this type of look-back (retrospective) learn about is “one thing that you must take with a grain of salt, for the reason that there are probably many variables that might affect the consequences that are not being accounted for.”

Intestine, director of the SIUH Publish-COVID Restoration Middle, cautioned in opposition to embracing HRT as a remedy choice for COVID amongst girls now not already taking it.

“There is a robust worry any time you prescribe HRT remedy, as a result of HRT carries important dangers,” he famous.

The ones dangers come with an greater possibility of blood clots and stroke in addition to endometrial and breast most cancers.

“It is usually unclear whether or not present utilization of hormones is essentially as useful for COVID sufferers as can be prior publicity to HRT,” Intestine mentioned.

The hazards of prescribing HRT as a COVID remedy would lengthen to each men and women — particularly males, he mentioned.

“It isn’t transparent whether or not males would get advantages, and giving them HRT would reveal them to dangers, reminiscent of blood clots, that they would not usually come upon,” Intestine mentioned.

The findings

General Article

May just Omega-3 Fatty Acids Combat Pimples?

News Picture: Could Omega-3 Fatty Acids Fight Acne?By way of Cara Murez HealthDay Reporter

WEDNESDAY, Would possibly 18, 2022 (HealthDay Information)

As many as 50 million American citizens handle pimples. The blemishes can also be painful and, for some, embarrassing.

Now, researchers will have discovered a brand new weapon to battle pimples — one with out harsh unwanted side effects.

A find out about in Germany has pinpointed omega-3 fatty acids — present in fish oil, wild salmon, nuts and seeds — as a nutrient useful for decreasing pimples.

Amongst 100 individuals with pimples, about 94% had low ranges of the fatty acid of their blood, the find out about came upon. Many additionally had upper ranges of a hormone identified to stimulate pimples manufacturing.

“As any individual who loves to regard pimples and any individual who plays medical trials, it is a very attention-grabbing find out about,” stated Dr. Sandra Johnson, a dermatologist in Citadel Smith, Ark. Johnson was once now not concerned within the find out about.

“We now have nice therapies for pimples, however they arrive at a monetary value in addition to attainable unwanted side effects,” Johnson stated. “It could be extra herbal, and not more dangerous and more cost effective to switch nutrition to regard pimples.”

The find out about findings have been launched ultimately week’s assembly of the Ecu Academy of Dermatology and Venereology. Analysis offered at clinical conferences must be regarded as initial till revealed in a peer-reviewed magazine.

Omega-3 fatty acids are recurrently present in non-farmed fish, algae and different plant-based meals, together with legumes, nuts and seeds.

The researchers stated those fatty acids cut back irritation via stimulating the frame to provide anti inflammatory prostaglandins E1 and E3 and leukotriene B5, and reducing ranges of IGF-1 (insulin-like expansion issue). IGF-1 is understood to urge pimples.

Lead find out about creator Dr. Anne Gürtler stated clinicians must supply sufferers with knowledge on nutritional alternatives as a part of a contemporary remedy way for pimples. She is within the division of dermatology and allergic reaction at Ludwig-Maximilian College in Munich, Germany.

When her group analyzed individuals’ blood samples, they discovered maximum had ranges of omega-3 fatty acids under the beneficial quantities of 8% to 11%.

Taking a look at particular person diets, the group discovered those that ceaselessly ate chickpeas and lentils, whilst abstaining from sunflower oil, had upper ranges of omega-3s. Sunflower oil has been present in previous analysis to worsen pimples.

The find out about sufferers who had decrease ranges of omega-3 fatty acids additionally had upper ranges of IGF-1. The ones with critical deficits in omega-3s, less than 4%, had much more IGF-1 hormone.

Researchers were having a look at nutritional affect on pimples for a few years, Johnson stated. But, the analysis has now not been of top quality as a result of there has now not been a lot investment for it.

Some suppose meals like donuts which are top in glycemic index, nuts, hormonally influenced meats and top iodine meals can irritate pimples, she stated.

Dairy and sugar are a few of the different nutritional culprits which were blamed for expanding pimples.

Dr. Debra Jaliman, a dermatologist in New York Town, stated she at all times discusses nutrition together with her sufferers, along with reviewing the goods they use on their pores and skin. Jaliman was once additionally now not concerned on this find out about.

“Omega-3 appears to be an important component in our nutrition in some ways,” Jaliman stated, noting its hyperlink to different well being advantages.

“I understand in my sufferers, once we trade other folks’s diets, I believe find it irresistible actually has an impact on their pimples, however it may be that, in fact, I am converting their conduct, I am including medicine. We do a large number of issues without delay. It is not like right here the place it is a managed find out about, however I do suppose it does have an impact,” Jaliman stated.

Topical hormone blockers, a brand new remedy, are some other trade that is revolutionizing the sphere of pimples remedy. The cream blocks extra male hormones at the pores and skin, with out requiring eating harsh, inside medicines, Jaliman stated. She known as it the most important leap forward in 30 years.




QUESTION


Pimples is the results of an allergic reaction.
See Solution

It is too early to mention whether or not an omega-3 complement created to scale back pimples consistent with blood serum ranges would toughen pores and skin, consistent with the researchers. Further find out about is wanted first.

Johnson stated she’d love to find out about any attainable unwanted side effects and what the optimum dose of omega-3 fatty acids may well be.

“Even supposing there don’t seem to be a large

General Article

Hints That Step forward CAR-T Treatment Would possibly Combat Forged Tumor Cancers

News Picture: Hints That Breakthrough CAR-T Therapy May Fight Solid Tumor CancersThrough Dennis Thompson HealthDay Reporter

MONDAY, April 11, 2022 (HealthDay Information)

An immune system-based remedy that is confirmed efficient towards blood cancers additionally may turn out helpful in combating cast tumor cancers, early medical trial knowledge display.

A small staff of sufferers with testicular and ovarian most cancers looked as if it would reply smartly to “CAR-T” remedy with immune method cells that had been genetically reengineered to focus on their tumors, researchers mentioned Sunday right through a presentation at an American Affiliation for Most cancers Analysis assembly, in New Orleans.

About 86% of sufferers with habitual or power most cancers had their tumor prevent rising or begin to shrink, and 43% had an important decline of their tumors, mentioned lead researcher Dr. John Haanen, a scientific oncologist on the Netherlands Most cancers Institute in Amsterdam.

“The good factor is also that it’s what we name an unmet want most cancers affected person inhabitants, as a result of there may be hardly ever the rest to be had for sufferers with testicular most cancers who have failed different traces of remedy,” Haanen mentioned. “So it is particularly great this remedy turns out to paintings so smartly.”

The experimental remedy featured an extra innovation in addition. Docs used an mRNA vaccine — created the use of the similar era that evolved the COVID-19 vaccines — to spice up some sufferers’ immune reaction towards the most cancers.

“The theory used to be that by way of doing that, those cells would additional extend and persist for a protracted little bit of time,” Haanen mentioned of the mRNA vaccine.

Since 2017, six chimeric antigen receptor T-cell (CAR-T) remedies were authorized by way of the U.S. Meals and Drug Management, interested in the remedy of blood cancers corresponding to leukemia and lymphoma.

On this remedy, a most cancers affected person’s personal immune cells are got rid of from their frame and engineered to raised hit upon their tumor cells. The trick is to search out goals at the tumor cells that don’t seem to be additionally discovered on wholesome cells.

Many blood cancers percentage a commonplace goal distinctive to tumor cells, and so CAR-T remedies have principally keen on them, mentioned Dr. Vincent Lam, an assistant professor of oncology at Johns Hopkins College in Baltimore.

It is also more difficult for CAR-T immune cells to shuttle to and infiltrate a cast organ tumor, in comparison to blood cancers, he added.

However for this trial, Haanen and his crew created a CAR-T remedy that specializes in a goal referred to as CLDN6 that is distinctive to a couple cast tumor cancers however now not expressed in wholesome tissue.

Prostate, ovarian and endometrial cancers, particularly, seem at risk of a CAR-T remedy concentrated on CLDN6, Haanen mentioned. (Endometrial most cancers starts within the lining of a lady’s uterus.)

Researchers examined the remedy in 16 sufferers, in early trials designed to test for protection and doable effectiveness.

Sufferers both gained the CAR-T cells by myself or with booster doses of CARVac, an mRNA vaccine evolved by way of BioNTech, the corporate that co-founded the primary COVID vaccine with Pfizer. BioNTech funded this learn about.

The mRNA vaccine, delivered intravenously, helped refresh the CAR-T reaction by way of prompting the spleen and lymph nodes to supply copies of CLDN6, a lot because the COVID vaccine produces copies of the virus’ spike protein, Haanen and Lam mentioned.

“That is in reality the primary medical knowledge that we need to display that … vaccines can probably spice up the CAR-T patience within the affected person’s frame, due to this fact affecting a harder reaction,” Lam mentioned.




SLIDESHOW


Pores and skin Most cancers Signs, Sorts, Pictures
See Slideshow

About 40% of the sufferers evolved cytokine unlock syndrome, a systemic irritation that is commonplace with immune-system remedies like monoclonal antibodies.

This aspect impact brought about fever and increased blood drive within the sufferers, however used to be “simply manageable” with medicine that reasonable immune reaction, Haanen mentioned.

Each Haanen and Lam warned that those effects are very early.

Protection trials are nonetheless ongoing, and the next move will probably be to check in sufferers with explicit varieties of most cancers, Haanen mentioned.

“We in reality nonetheless have an extended option to move to in reality achieve enough self assurance that this actually will paintings,” Lam mentioned. “However it is unquestionably an overly promising sign.”

Findings introduced at scientific conferences are thought to be initial till printed in a peer-reviewed magazine.

Additional information

The U.S. Nationwide Most cancers Institute has extra on CAR-T remedy.

SOURCES: John Haanen, MD, PhD, scientific oncologist, Netherlands Most cancers Institute, Amsterdam; Vincent Lam, MD, assistant professor, oncology, Johns Hopkins College, Baltimore; April 10, 2022, presentation, American Affiliation for Most cancers Analysis,